A first-of-its-kind epidemiologic study shows a link between exposure to organophosphate flame retardants (PFRs) and infertility.
A first-of-its-kind epidemiologic study shows a link between exposure to organophosphate flame retardants (PFRs) and infertility. The results, in women recruited from an academic fertility clinic, reflect levels of exposure that are not abnormal or high, say the researchers.
Published in Environmental Health Perspectives, the analysis included 211 women enrolled in the Environment And Reproductive Health (EARTH) prospective cohort study who provided 1 or 2 urine samples per in vitro fertilization (IVF) cycle. Established in 2004, EARTH was designed to evaluate environmental and dietary determinants of fertility from patients undergoing assisted reproduction at the Massachusetts General Hospital Fertility Center.
The average age of the participants was 35, 87% were white, 75% had never smoked and 34% had a prior pregnancy. The cause of infertility was female factor in 36%, male factor in 29%, and unexplained in 35% of the cases.
The five PFS metabolites examined in the women’s urine were [bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), diphenyl phosphate (DPHP), isopropylphenyl phenyl phosphate (ip-PPP), tert-butylphenyl phenyl phosphate (tb-PPP), and bis(1-chloro-2-propyl phosphate (BCIPP). They were measured with negative electrospray ionization liquid chromatography tandem mass spectrometry (LC-MS/MS). Multivariable generalized linear mixed models were used to evaluate the association between PFR metabolites and IVF outcomes, accounting for multiple IVF cycles per woman.
According to researchers from the National Institute of Environmental Health Sciences, PFRs are commonly used in consumer products that contain polyurethane foam. They are alternatives to polybrominated diphenyl ethers (PBDEs), which had been used in the foam and electronics but were phased out in the mid-2000s because of concerns about persistence, bioaccumulation, and toxicity.
In the epidemiologic study, 3 of the PFS metabolites were detected at high frequency in urine samples-BDCIPP 87%, DPHP 94%, and ip-PPP 80%-whereas detection frequencies were low for tb-PPP and BCIPP (14% and 0%, respectively). In the adjusted multivariable models, decreased success for several IVF outcomes was seen across increasing quartiles of both summed and individual PFR metabolites. Significant decreases in adjusted means from the lowest to highest quartile of mean PFR were observed in the proportion of cycles resulting in successful fertilization (10% decrease, P trend = 0.04), implantation (31%, P trend = 0.02), clinical pregnancy (41%, P trend = 0.004) and live birth (38%, P trend = 0.05).
The PFR metabolite concentrations in the women’s urine, the authors noted, was similar to or lower than that in other adult populations in the United States, Norway and Australia. Their research, they said, is the first epidemiologic study to explore the effects of PFRs on female reproduction. The findings may be more relevant to older women because the mean age of the population was 35 years but are limited by the fact that male partner exposure to PFRs was not considered and may contribute to the association that was observed.
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More